ATOS Atossa Therapeutics, Inc.
Healthcare$4.96-0.20%ClosedMarket Cap: $42.7M
As of 2026-05-25
Insider Statistics (Q2 2026)
Acquisitions
6
Dispositions
0
Buy/Sell Ratio
0.00
Net Shares
+60,000
Shares Acquired
60,000
Shares Disposed
0
Total Bought ($)
$0.00
Total Sold ($)
$0.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Thu May 14 | Steinhart Richard I | director | Sell | 10,000 | $0.00 | 10,000 |
| Thu May 14 | Remmel H. Lawrence | director | Sell | 10,000 | $0.00 | 10,683 |
| Thu May 14 | Galli Stephen J | director | Sell | 10,000 | $0.00 | 10,006 |
| Thu May 14 | Finn Jonathan | director | Sell | 10,000 | $0.00 | 11,666 |
| Thu May 14 | Cigler Tessa | director | Sell | 10,000 | $0.00 | 10,000 |
| Thu May 14 | Chen Shu-Chih | director | Sell | 10,000 | $0.00 | 10,000 |
| Tue Mar 31 | QUAY STEVEN C | director, officer: President & CEO | Sell | 65,000 | $0.00 | 88,038 |
| Mon Mar 30 | Daniel Mark James | officer: Chief Financial Officer | Sell | 63,000 | $0.00 | 63,000 |
| Fri Jan 30 | QUAY STEVEN C | director, officer: President & CEO | Sell | 331,674 | $0.00 | 345,572 |
| Thu Jan 22 | QUAY STEVEN C | director, officer: President & CEO | Sell | 950,000 | $0.60 | 950,000 |
| Thu Jan 22 | QUAY STEVEN C | director, officer: President & CEO | Sell | 325,203 | $0.00 | 339,101 |
| Tue Oct 21 | Daniel Mark James | officer: Chief Financial Officer | Sell | 578,000 | $1.03 | 578,000 |
| Tue Oct 21 | Daniel Mark James | Sell | 0 | $0.00 | 0 | |
| Thu May 22 | QUAY STEVEN C | director, officer: President & CEO | Buy | 11,239 | $0.88 | 13,898 |
| Fri May 16 | Rees Heather | officer: Chief Financial Officer | Sell | 543,785 | $0.99 | 543,785 |